|
Volumn 121, Issue 5 SUPPL., 2002, Pages 197S-200S
|
5-Lipoxygenase inhibitors for the treatment of COPD
|
Author keywords
5 lipoxygenase; 5 lipoxygenase inhibitor; Antagonist; COPD; Leukotriene; Leukotriene B4; Neutrophil
|
Indexed keywords
2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID;
3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID;
ARACHIDONATE 5 LIPOXYGENASE;
CELL NUCLEUS RECEPTOR;
LEUKOTRIENE B4 RECEPTOR ANTAGONIST;
LEUKOTRIENE RECEPTOR;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LIPOXYGENASE INHIBITOR;
PLACEBO;
POBILUKAST;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SB 201146;
ZK 151657;
ZK 158252;
ZK 183838;
AIRWAY;
CELL LINEAGE;
CELL NUCLEUS MEMBRANE;
CELL SURFACE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONFERENCE PAPER;
DRUG INHIBITION;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HUMAN;
IN VIVO STUDY;
INFLAMMATION;
LUNG FUNCTION;
MOLECULAR EVOLUTION;
MONOCYTE;
NONHUMAN;
PRIORITY JOURNAL;
REDUCTION;
|
EID: 0036257558
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.121.5_suppl.197S Document Type: Conference Paper |
Times cited : (44)
|
References (15)
|